EINSCHLUSSKRITERIEN

• Age > 18 years
• histologically proven low-grade glioma 
• indication for definitive or adjuvant radiotherapy
• ability to understand character and personal consequences of the clinical trial
• written informed consent

AUSSCHLUSSKRITERIEN

• previous cerebral irradiation
• contraindication for contrast-enhanced MRI 
• neurofibromatosis